Our Bodies Ourselves, September 8, 2015. It’s been almost impossible to ignore the media fascination with “pink Viagra” and the public debate about whether the drug flibanserin — soon to go sale as Addyi — should have been approved last month by the Food and Drug Administration. Find out the facts here.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Approves ‘Female Viagra’ Drug
Politico, August 18, 2015. FDA has approved the so-called female Viagra drug despite safety concerns, and we’re worried about what they will approve next.
Read More »A Congressional Attempt to Speed The Development Of Lifesaving Treatments
NPR, July 30, 2015. Listen to NCHR president Dr. Diana Zuckerman explain her concerns about a new health bill.
Read More »Delayed Scrutiny: Problems with Birth Control Device Expose Gaps in FDA Oversight
Modern Healthcare, July 25, 2015. More than 19,000 women have joined a Facebook support group called Essure Problems. Many have reported debilitating abdominal pain, heavy bleeding and large weight fluctuations. They claim these side effects were not disclosed to them by the manufacturer or their doctors, and that their complaints have been dismissed for years by the device manufacturer, physicians and the federal government.
Read More »CMS Panel Moderately Confident that some PAD Treatments Warrant National Coverage
Healio, July 22, 2015. “We have a conflict between what we know logically should work [and] data that … just aren’t very good,” panel member Diana Zuckerman, PhD, president of the National Center for Health Research Cancer Prevention and Treatment Fund, said. She was one of several panelists who emphasized the need for more long-term data.
Read More »